Neurodegenerative diseases such as Alzheimer's/Dementia (AD) and Parkinson's Disease (PD) are two of the most common age-related neurological conditions. These diseases progress over time, and result in a slowing of physical, neurological and cognitive processes. Unfortunately these diseases are not curable, however treatment initiatives are geared toward increasing neurological integration – particularly in areas of neurological function which have been shown to be deficient as a result of clinical testing. The goal is thus to offer the patient the potential to maximize neurological functionality for the longest possible duration of time to potentially slow the progression of the disease, and improve quality of life. The brain is capable of plasticity, change, and increased integration as a result of specific therapeutic interventions at all ages. This allows us to build a customized treatment intervention aimed at helping these patients and their families to potentially enjoy increased function for a longer duration of time.